Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction

被引:25
作者
Yli-Jama, P
Seljeflot, I
Meyer, HE
Hjerkinn, EM
Arnesen, H
Pedersen, JI
机构
[1] Univ Oslo, Inst Nutr Res, N-0316 Oslo, Norway
[2] Ulleval Univ Hosp, Clin Res Ctr, Oslo, Norway
关键词
adhesion molecules; atherosclerosis; endothelial dysfunction; free fatty acids; hemostasis; non-esterified fatty acids; polyunsaturated; fatty acids;
D O I
10.1016/S0021-9150(02)00067-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to investigate the pattern of serum non-esterified fatty acid (NEFA) fraction in association with atherosclerosis development. We have studied possible relationships between eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA) in the NEFA fraction and biochemical markers of endothelial activation or dysfunction. The study population consisted of 152 elderly men with high risk for coronary heart disease. The composition of fasting serum NEFA was analysed by gas-liquid chromatography. Endothelial activation was evaluated using biochemical analyses of some markers of endothelial function. A significant inverse linear association was found between serum non-esterified EPA and DHA, and soluble vascular cell adhesion molectile-1 (sVCAM-1) (P = 0.02 and 0.001, respectively). An inverse linear association was found between serum non-esterified AA and sVCAM-1 (P = 0.001) and von Willebrand Factor (P = 0.005). The significant inverse associations for DHA and AA were independent from the serum content of other NEFAs. Taken together, negative associations were found between sVCAM-1 and the serum levels of non-esterified DHA, EPA and AA. The inverse relation between the levels of sVCAM-1 and very long-chain n-3 fatty acids might indicate an anti-inflammatory effect of the latter. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 33 条
[1]   High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease [J].
Carlsson, M ;
Wessman, Y ;
Almgren, P ;
Groop, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1588-1594
[2]   Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects [J].
Conquer, JA ;
Cheryk, LA ;
Chan, E ;
Gentry, PA ;
Holub, BJ .
THROMBOSIS RESEARCH, 1999, 96 (03) :239-250
[3]  
De Caterina R, 1998, J LIPID RES, V39, P1062
[4]   THE OMEGA-3-FATTY-ACID DOCOSAHEXAENOATE REDUCES CYTOKINE-INDUCED EXPRESSION OF PROATHEROGENIC AND PROINFLAMMATORY PROTEINS IN HUMAN ENDOTHELIAL-CELLS [J].
DECATERINA, R ;
CYBULSKY, MI ;
CLINTON, SK ;
GIMBRONE, MA ;
LIBBY, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (11) :1829-1836
[5]   OMEGA-3-FATTY-ACIDS AND ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES [J].
DECATERINA, R ;
CYBULSKY, MA ;
CLINTON, SK ;
GIMBRONE, MA ;
LIBBY, P .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1995, 52 (2-3) :191-195
[6]   Novel mode of action of iloprost: in vitro downregulation of endothelial cell adhesion molecules [J].
Della Bella, S ;
Molteni, M ;
Mocellin, C ;
Fumagalli, S ;
Bonara, P ;
Scorza, R .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 65 (2-3) :73-83
[7]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[8]   Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta [J].
Forman, BM ;
Chen, J ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4312-4317
[9]   Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension [J].
Friedman, R ;
Mears, JG ;
Barst, RJ .
CIRCULATION, 1997, 96 (09) :2782-2784
[10]   Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia [J].
Goodfellow, J ;
Bellamy, MF ;
Ramsey, MW ;
Jones, CJH ;
Lewis, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) :265-270